Dr. Marshall's research focuses on the genetics of prostate cancer, as well as clonal hematopoiesis, a risk factor for cardiovascular disease that may be relevant to prostate cancer
Reflections on the spring conference season, including highlights from the recent Group Meeting; updates on the ComboMATCH precision medicine initiative
The Group is recognizing Dr. Forde as an exceptional physician-scientist who is making significant research contributions as a translational thoracic cancer investigator
The Group is recognizing Dr. Forastiere for her sustained commitment to developing women’s careers in cancer medicine and advancing women investigators in ECOG-ACRIN
Health care administrator Charmaine Green shares her experience supporting cancer clinical trials and discusses how her role has evolved over the years
The Group is recognizing Dr. Eads as an exceptional medical oncologist and committed educator who is making significant research contributions as an international disease expert in neuroendocrine tumors and gastroesophageal malignancies